please keep our community civil. comments should remain on topic and be respectful.
.
biohaven: "rimegepant pivotal phase 3 trial results -- conference call."
https://grassfed.us/Sieberg-neighbour-of-Hano-from-Nispen
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
orchid pharma faces liquidation as lenders reject resolution plan
.
photos
.
.
.
.
.